Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for CPB-Induced Hypogammaglobulinemia in Infants
NCT02043379Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2014
- Primary completion
- Jun 2015
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, double-blind trial of polyvalent human immunoglobulin in hypogammaglobulinemia, sponsored by University of Alabama at Birmingham. Primary endpoints: Post-Operative Infections, Post-operative Infection at 1 week and 2 more. Started May 2014; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
hypogammaglobulinemia
Beyond the preview
Go deeper on NCT02043379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02043379.